Status:
UNKNOWN
Noninvasive Internal Jugular Venous Oximetry
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Neoplasms
Eligibility:
All Genders
20-70 years
Brief Summary
In this study, we are developing a novel plethysmographic monitoring device which incorporates several key techniques: inclusion of structural information (ultrasound image), coupling with the estimat...
Detailed Description
Central venous oxygen (ScvO2) is an important index for evaluating tissue perfusion in clinical care. To obtain the ScvO2 value, blood analysis must be obtained through a central venous catheter (CVC)...
Eligibility Criteria
Inclusion
- Patients undergoing major cancer surgery that requires central venous catheter placement
- Cancer patients undergoing totally implantable venous access device placement
Exclusion
- Susepct infectious symptoms and signs (eg. white blood cell count count \>10000 ; fever \>38.3℃)
- impaired liver functions (aspartate aminotransferase\> 100 U/L); impaired renal function (estimated glomerular filtration rate \<60 mL/min/1.73 m2)
- heart failure, with New York Heart Associatation class 2 or more
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06004466
Start Date
September 1 2023
End Date
September 1 2024
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100